1. Home
  2. ENOV vs NYAX Comparison

ENOV vs NYAX Comparison

Compare ENOV & NYAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • NYAX
  • Stock Information
  • Founded
  • ENOV 1995
  • NYAX 2005
  • Country
  • ENOV United States
  • NYAX Israel
  • Employees
  • ENOV N/A
  • NYAX N/A
  • Industry
  • ENOV Fluid Controls
  • NYAX
  • Sector
  • ENOV Industrials
  • NYAX
  • Exchange
  • ENOV Nasdaq
  • NYAX Nasdaq
  • Market Cap
  • ENOV 1.7B
  • NYAX 1.7B
  • IPO Year
  • ENOV 2008
  • NYAX N/A
  • Fundamental
  • Price
  • ENOV $33.80
  • NYAX $44.32
  • Analyst Decision
  • ENOV Strong Buy
  • NYAX Buy
  • Analyst Count
  • ENOV 5
  • NYAX 6
  • Target Price
  • ENOV $58.00
  • NYAX $38.33
  • AVG Volume (30 Days)
  • ENOV 1.6M
  • NYAX 20.8K
  • Earning Date
  • ENOV 08-06-2025
  • NYAX 08-06-2025
  • Dividend Yield
  • ENOV N/A
  • NYAX N/A
  • EPS Growth
  • ENOV N/A
  • NYAX N/A
  • EPS
  • ENOV N/A
  • NYAX 0.18
  • Revenue
  • ENOV $2,150,191,000.00
  • NYAX $331,161,000.00
  • Revenue This Year
  • ENOV $8.23
  • NYAX $33.44
  • Revenue Next Year
  • ENOV $6.18
  • NYAX $23.74
  • P/E Ratio
  • ENOV N/A
  • NYAX $268.40
  • Revenue Growth
  • ENOV 18.32
  • NYAX 34.05
  • 52 Week Low
  • ENOV $28.83
  • NYAX $20.31
  • 52 Week High
  • ENOV $49.83
  • NYAX $52.46
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 57.12
  • NYAX 43.17
  • Support Level
  • ENOV $32.74
  • NYAX $48.08
  • Resistance Level
  • ENOV $33.82
  • NYAX $52.46
  • Average True Range (ATR)
  • ENOV 1.15
  • NYAX 1.41
  • MACD
  • ENOV 0.34
  • NYAX -0.36
  • Stochastic Oscillator
  • ENOV 97.07
  • NYAX 3.67

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It provides consumers with digital, cashless payments, and connected commerce experiences, enhancing consumer conversion and loyalty. Its platform addresses the entire unattended commerce value chain, including a payments infrastructure, a commerce software suite, a consumer engagement platform, and integrated POS devices. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

Share on Social Networks: